1. Home
  2. REGN vs EQIX Comparison

REGN vs EQIX Comparison

Compare REGN & EQIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regeneron Pharmaceuticals Inc.

REGN

Regeneron Pharmaceuticals Inc.

N/A

Current Price

$958.53

Market Cap

84.3B

Sector

Health Care

ML Signal

N/A

Logo Equinix Inc. REIT

EQIX

Equinix Inc. REIT

N/A

Current Price

$1,053.58

Market Cap

103.1B

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
REGN
EQIX
Founded
1988
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
84.3B
103.1B
IPO Year
1995
2000

Fundamental Metrics

Financial Performance
Metric
REGN
EQIX
Price
$958.53
$1,053.58
Analyst Decision
Buy
Strong Buy
Analyst Count
28
35
Target Price
$977.93
★ $1,234.88
AVG Volume (30 Days)
★ 900.8K
662.9K
Earning Date
10-30-2026
10-28-2026
Dividend Yield
0.40%
★ 1.92%
EPS Growth
8.19
★ 61.88
EPS
★ 37.37
13.96
Revenue
$5,872,227,000.00
★ $5,998,545,000.00
Revenue This Year
$30.96
$11.78
Revenue Next Year
$7.28
$11.30
P/E Ratio
★ $25.47
$76.91
Revenue Growth
★ 20.82
7.85
52 Week Low
$591.52
$720.62
52 Week High
$991.73
$1,128.68

Technical Indicators

Market Signals
Indicator
REGN
EQIX
Relative Strength Index (RSI) 68.96 55.48
Support Level $747.82 $1,046.20
Resistance Level $991.73 $1,082.17
Average True Range (ATR) 36.85 34.98
MACD 5.63 7.67
Stochastic Oscillator 82.95 74.26

Price Performance

Historical Comparison
REGN
EQIX

About REGN Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.

About EQIX Equinix Inc. REIT

Equinix is one of the leading providers of cloud- and carrier-neutral data centers, offering colocation and interconnection services to hyperscalers and businesses. Equinix operates 270 properties in 77 metropolitan areas across 36 countries, serving over 10,000 customers. About 70% of Equinix's revenue comes from renting physical space, which allows hyperscalers and other clients to store servers, data storage, and networking equipment. The other 30% of revenue is generated primarily through interconnection services (20%) and other managed services (10%).

Share on Social Networks: